Scientists have identified genetic variants associated with slightly greater weight loss and the incidence of side effects in people taking glucagon-like peptide-1 (GLP-1) receptor agonists. The ...

LEWES, Del., April 13, 2026 /PRNewswire/ -- The global Portable Blenders Market is estimated at USD 371 Million in 2025 and is forecast to touch USD 764 Million by 2035, growing at a CAGR of 7.5% ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces ...

Gary Player, Jack Nicklaus and Tom Watson got the Masters underway on Thursday, hitting the ceremonial first tee shots on a ...

Kara Swisher begins her new CNN series on longevity and health in a cemetery, reflecting on her father's death. The series, ...

Welcome back to another edition of This Week in Farming, your one stop-shop for the best Farmers Weekly content of the past ...

CNW/ - Health Canada has granted a Notice of Compliance (NOC) for Saphnelo® (anifrolumab injection) for subcutaneous self-administration via a ...

The Stevia Sugar Blends Market is gaining momentum due to rising consumer awareness regarding sugar-related health risks such as diabetes, obesity, and cardiovascular diseases. Increasing demand ...

For the past 7 years, pharmaceuticals that work as glucagon-like peptide 1 (GLP-1) receptor agonists have dominated the weight-loss and diabetes markets. These drugs, currently so ...

Scientists at the Buck Institute for Research on Aging, along with collaborators at UC San Francisco, have discovered that APOE4, the most common genetic risk factor for Alzheimer's disease, causes ...

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling ...

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling precise correction, ...